ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Endocrinology, Diabetes Metabolism

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,067Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 448

$1.01M Total Retail Price of All Prescriptions

Rank: 23 out of 448

373 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 373 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Risky Drugs to Seniors

1% of this provider’s 5,421 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

47% of this provider’s prescriptions were for brand-name drugs, compared to an average of 45%.

Prescription Price

$143 was the average price of a prescription from this provider, compared to $111 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
SIMVASTATIN 318 260 1 4
SYNTHROID 256 170 2 3
ZETIA 238 187 3 41
METFORMIN HCL 218 153 4 2
PRANDIN 196 155 5 51
PEN NEEDLE 176 142 6 5
LOSARTAN POTASSIUM 164 127 7 16
NOVOLOG FLEXPEN 162 137 8 28
LEVOTHYROXINE SODIUM 159 119 9 1
BYETTA 156 118 10 47
VICTOZA 3-PAK 133 99 11 64
HYDROCODONE-ACETAMINOPHEN 131 56 S3 12 33
ALLOPURINOL 125 112 13 48
LEVEMIR FLEXPEN 119 112 14 35
TAMSULOSIN HCL 114 110 15 46
LANTUS SOLOSTAR 95 71 16 10
AMLODIPINE BESYLATE 94 74 17 12
BYDUREON 91 82 18 80
CRESTOR 91 75 18 22
VYTORIN 86 77 20 107
ZOLPIDEM TARTRATE 83 69 21 37
ATORVASTATIN CALCIUM 77 46 22 13
JANUVIA 77 66 22 6
NAPROXEN 74 54 24 133
LANTUS 71 42 25 8
VICTOZA 2-PAK 69 58 26 135
LISINOPRIL 67 51 27 14
ATENOLOL 66 64 28 29
DIOVAN 64 40 29 23
LOSARTAN-HYDROCHLOROTHIAZIDE 59 48 30 50
NOVOLOG 53 24 31 34
TRICOR 52 52 32 106
ALENDRONATE SODIUM 50 45 33 17
POTASSIUM CHLORIDE 50 37 33 55
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 13, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.